CAS 114903-05-8
:Fondaparinux sodique N-3
Description :
Le fondaparinux sodique, avec le numéro CAS 114903-05-8, est un anticoagulant synthétique qui appartient à la classe de médicaments connus sous le nom de pentasaccharides. Il est principalement utilisé pour la prévention et le traitement de la thromboembolie veineuse et est particulièrement efficace chez les patients subissant une chirurgie orthopédique ou abdominale. Le fondaparinux agit en inhibant sélectivement le facteur Xa, un composant essentiel de la cascade de coagulation, empêchant ainsi la formation de caillots sanguins. Ce composé se caractérise par sa haute biodisponibilité et sa pharmacocinétique prévisible, ce qui permet une administration sous-cutanée sans avoir besoin de surveiller régulièrement les paramètres de coagulation. Le fondaparinux sodique est soluble dans l'eau et a un poids moléculaire relativement faible, ce qui contribue à son profil pharmacologique favorable. De plus, il a une longue demi-vie, ce qui permet une posologie une fois par jour. Comme pour tout anticoagulant, il est essentiel de surveiller les complications hémorragiques potentielles et les contre-indications, en particulier chez les patients présentant une insuffisance rénale ou des troubles hémorragiques actifs.
Formule :C81H91N7O27
InChI :InChI=1S/C81H91N7O27/c1-99-76-58(84-81(98)106-46-53-35-21-8-22-36-53)65(101-41-48-25-11-3-12-26-48)64(56(39-91)107-76)111-79-61(93)67(103-43-50-29-15-5-16-30-50)69(71(114-79)74(94)95)112-77-57(85-87-82)60(92)62(54(37-89)108-77)110-80-73(105-45-52-33-19-7-20-34-52)68(104-44-51-31-17-6-18-32-51)70(72(115-80)75(96)97)113-78-59(86-88-83)66(102-42-49-27-13-4-14-28-49)63(55(38-90)109-78)100-40-47-23-9-2-10-24-47/h2-36,54-73,76-80,89-93H,37-46H2,1H3,(H,84,98)(H,94,95)(H,96,97)/t54-,55-,56-,57-,58-,59-,60-,61-,62-,63-,64-,65-,66-,67-,68+,69+,70+,71-,72+,73-,76+,77-,78-,79-,80-/m1/s1
Code InChI :InChIKey=YJFUPTPXBAYHGB-JFHRUGPCSA-N
SMILES :O([C@H]1[C@H](OCC2=CC=CC=C2)[C@@H](OCC3=CC=CC=C3)[C@H](O[C@@H]4[C@@H](CO)O[C@H](O[C@H]5[C@H](OCC6=CC=CC=C6)[C@@H](O)[C@H](O[C@H]7[C@H](OCC8=CC=CC=C8)[C@@H](NC(OCC9=CC=CC=C9)=O)[C@@H](OC)O[C@@H]7CO)O[C@H]5C(O)=O)[C@H](N=[N+]=[N-])[C@H]4O)O[C@@H]1C(O)=O)[C@@H]%10[C@H](N=[N+]=[N-])[C@@H](OCC%11=CC=CC=C%11)[C@H](OCC%12=CC=CC=C%12)[C@@H](CO)O%10
Synonymes :- Fondaparinux Sodium intermediate N-3
- Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-<span class="text-smallcaps">D</smallcap>-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-<smallcap>D</smallcap>-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-<smallcap>D</smallcap>-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-<smallcap>L</smallcap>-idopyranuronosyl-(1→4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-α-<smallcap>D</span>-glucopyranoside
- Methyl-O-(2-azido-3,4-di-O-benzyl-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(2,3-di-Obenzyl-β-D-glucopyranosyluronicacid)-(1-4)-O-(2-azido-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(3-O-benzyl-a-L-idopyranosyluronic acid)-(1-4)-3-O-benzyl-2-benzyloxycarbonylamino-2-deoxy-a-D-glucopyranoside
- N-3 Intermediate, Fondaparinux
- N-3 for Fondaparinux sodium
- Pentasaccharide N-3 Intermediate
- α-<span class="text-smallcaps">D</smallcap>-Glucopyranoside, methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-<smallcap>D</smallcap>-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-<smallcap>D</smallcap>-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-<smallcap>D</smallcap>-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-<smallcap>L</span>-idopyranuronosyl-(1→4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-
- Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-D-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-D-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-D-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-α-D-glucopyranoside
- α-D-Glucopyranoside, methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-D-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-D-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-D-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-
- Methyl-O-(2-azido-3,4-di-O-benzyl-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(2,3-di-O-benzyl-b-D-glucopyranosyluronicacid)- (1-4)-O-(2-azido-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(3-O-benzyl-a-L-idopyranosyluronic acid)-(1-4)-3-O-benzyl- 2-benzyloxycarbonylamino-2-deoxy-a-D-glucopyranoside
- -4-(benzyloxy)-6-methoxytetrahydr
- Methyl O-2-Azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-D-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-D-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-D-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-L-i
- a-D-Glucopyranoside, Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14) -O-2,3-bis-O-(phenylMethyl)-b-D-glucopyranuronosyl-(14)-O-2-azido- 2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-(phenylMethyl)-a-L-idopyranu ronosyl-(14)-2-deoxy-2 ISO 9001:2015 REACH
- Fondaparinux Sodium intermediate N3
- Fondaparinux interMediate N-3
- Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-alpha-D-glucopyranosyl-(1→
- Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-alpha-D-glucopyranosyl-(1-4)-O-2,3-bis-O-(phenylmethyl)-beta-D-glucopyranuronosyl-(1-4)-O-2-azido-2-deoxy-alpha-D-glucopyranosyl-(1-4)-O-3-O-(phenylmethyl)-alpha-L-idopyranuronosyl-(1-4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside
- (((2R,3S,4R,5R,6S)-5-azido-2-((benzoyloxy)methyl)
- Fondaparinux Sodium N3 Intermediate
- -2H-pyran-2-yl)oxy)-6-
- US-DMF No.: 028552
- Fondaparinux sodiuM N-3
- N-3 Fondaparinux API
- Fondaparinux Sodium intermediate
- Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-alpha-D-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-beta-D-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-alpha-D-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-alpha-L-idopyranuronosyl-(1→4)-2-deoxy-2-[[(pheny
- 4)-O-2,3-bis-O-(phenylmethyl)-beta-D-glucopyranuronosyl-(1→
- -3-azido-4,5-bis(benzyloxy)tetrahydro
- 4)-O-2-azido-2-deoxy-alpha-D-glucopyranosyl-(1→
- 4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-alpha-D-glucopyranoside
- a-D-Glucopyranoside,MethylO-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14)-O-2,3-bis-O-(phenylMethyl)-b-DChemicalbook-glucopyranuronosyl-(14)-O-2-azido-2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-(phenylMethyl)-a-L-idopyranuronosyl-(14)-2-deoxy-2
- 4)-O-3-O-(phenylmethyl)-alpha-L-idopyranuronosyl-(1→
- a-D-Glucopyranoside, Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14) -O-2,3-bis-O-(phenylMethyl)-b-D-glucopyranuronosyl-(14)-O-2-azido- 2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-
- a-D-Glucopyranosid
- a-D-Glucopyranoside, Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylMethyl)-a-D-glucopyranosyl-(14) -O-2,3-bis-O-(phenylMethyl)-b-D-glucopyranuronosyl-(14)-O-2-azido- 2-deoxy-a-D-glucopyranosyl-(14)-O-3-O-(phenylMethyl)-a-L-idopyranu ronosyl-(14)-2-deoxy-2
- (((2R,3S,4R,5R,6R)-5-azido-6-(((2S,3S,4S,5R,6R)-6-
- (2S,3S,4S,5R,6R)-methyl 3-(((2R,3S,4S,5S)-6-(acetoxymethyl)
- Voir plus de synonymes
Trier par
Degré de pureté (%)
0
100
|
0
|
50
|
90
|
95
|
100
2 produits concernés.
Methyl O-2-azido-2-deoxy-3,4-bis-O-(phenylmethyl)-α-D-glucopyranosyl-(1→4)-O-2,3-bis-O-(phenylmethyl)-β-D-glucopyranuronosyl-(1→4)-O-2-azido-2-deoxy-α-D-glucopyranosyl-(1→4)-O-3-O-(phenylmethyl)-α-L-idopyranuronosyl-(1→4)-2-deoxy-2-[[(phenylmethoxy)carbonyl]amino]-3-O-(phenylmethyl)-α-D-glucopyranoside
CAS :Formule :C81H91N7O27Masse moléculaire :1594.6199Methyl-O-(2-azido-3,4-di-O-benzyl-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(2,3-di-O-benzyl-b-D-glucopyranosyluronicacid)- (1-4)-O-(2-azi do-2-deoxy-a-D-glucopyranosyl)-(1-4)-O-(3-O-benzyl-a-L-idopyranosyluronic acid)-(1-4)-3-O-benzyl- 2-benzyloxycarbonyla
CAS :<p>Maltodextrin is a polysaccharide that is made up of glucose units linked together by alpha-glycosidic bonds. Maltodextrin is commonly used as a food additive, but it also has several industrial applications. It can be used to produce escherichia coli, which is a bacterium that produces maltose and amylopectin. Maltodextrin can also be used as an animal feed supplement or as an ingredient in baby food. The glycosidic bond between the glucose units are metabolized by mouse enzymes to produce maltose and glycogen, which are both plant metabolites. Maltodextrin consists of unbranched subunits with linear chains of alpha-1,4-linked glucose residues that have alpha-1,6-linked branches at every second residue. This means that maltodextrin has a glycosidic linkage between the two glucose molecules in the chain and one of these links will always be an alpha-</p>Formule :C81H91N7O27Degré de pureté :Min. 95%Masse moléculaire :1,594.62 g/mol

